CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -100.0% | 16,868 | -95.3% | 0.00% | -100.0% |
| Q3 2022 | $60,000 | -37.5% | 362,544 | +286.9% | 0.00% | 0.0% |
| Q3 2021 | $96,000 | -27.8% | 93,705 | +29.1% | 0.00% | 0.0% |
| Q2 2021 | $133,000 | +77.3% | 72,601 | +91.0% | 0.00% | 0.0% |
| Q1 2021 | $75,000 | -21.1% | 38,005 | +234.6% | 0.00% | -50.0% |
| Q2 2020 | $95,000 | +61.0% | 11,359 | +4.2% | 0.00% | +100.0% |
| Q4 2019 | $59,000 | -55.3% | 10,897 | -42.9% | 0.00% | -80.0% |
| Q2 2019 | $132,000 | – | 19,080 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |